Valerio Therapeutics (XPAR:ALVIO) Days Sales Outstanding : 191.52 (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Valerio Therapeutics Days Sales Outstanding?

Valerio Therapeutics's average Accounts Receivable for the six months ended in Dec. 2023 was €1.89 Mil. Valerio Therapeutics's Revenue for the six months ended in Dec. 2023 was €1.80 Mil. Hence, Valerio Therapeutics's Days Sales Outstanding for the six months ended in Dec. 2023 was 191.52.

The historical rank and industry rank for Valerio Therapeutics's Days Sales Outstanding or its related term are showing as below:

XPAR:ALVIO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 7.6 Med: 156.13 Max: 1264.6
Current: 340.87

During the past 13 years, Valerio Therapeutics's highest Days Sales Outstanding was 1264.60. The lowest was 7.60. And the median was 156.13.

XPAR:ALVIO's Days Sales Outstanding is ranked worse than
89.59% of 893 companies
in the Biotechnology industry
Industry Median: 72.43 vs XPAR:ALVIO: 340.87

Valerio Therapeutics's Days Sales Outstanding declined from Dec. 2022 (352.99) to Dec. 2023 (191.52).

Valerio Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Valerio Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valerio Therapeutics Days Sales Outstanding Chart

Valerio Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

205.65

1,028.31

682.02

1,264.60

340.87

Valerio Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															380.58	-	352.99	-	191.52

Competitive Comparison of Valerio Therapeutics's Days Sales Outstanding

For the Biotechnology subindustry, Valerio Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valerio Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valerio Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Valerio Therapeutics's Days Sales Outstanding falls into.

Valerio Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Valerio Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1.473	+	1.889)	/	2 )	/	1.8	*	365
=	1.681					/	1.8	*	365
=	340.87

Valerio Therapeutics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	1.889)	/	1 )	/	1.8	*	365 / 2
=	1.889					/	1.8	*	365 / 2
=	191.52

Valerio Therapeutics (XPAR:ALVIO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Valerio Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Valerio Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Valerio Therapeutics (XPAR:ALVIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valerio Therapeutics (XPAR:ALVIO) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

C4X:Germany

Address

49 Boulevard du General, Martial Valin, Paris, FRA, 75015

Website

https://www.valeriotx.com

Valerio Therapeutics is a clinical-stage biotechnology company designing and developing novel oncology drugs targeting tumor DNA repair functions. Its therapeutic strategy focuses on fighting tumor resistance to treatments, which poses ever-greater therapeutic challenges, especially in aggressive or rare cancers. its approach is based upon unique mechanisms of action on DNA Damage Response. The company focuses on bringing first-in-class and disruptive compounds from preclinical research to proof-of-concept in man in cancer indications with high unmet needs.

Valerio Therapeutics (XPAR:ALVIO) Headlines

No Headlines